Sotera Health Company (SHC)

USD 13.2

(0.92%)

Operating Expenses Summary of Sotera Health Company

  • Sotera Health Company's latest annual operating expenses in 2023 was 300.46 Million USD , down -49.17% from previous year.
  • Sotera Health Company's latest quarterly operating expenses in 2024 Q2 was 52.16 Million USD , up 0.67% from previous quarter.
  • Sotera Health Company reported a annual operating expenses of 308.65 Million USD in annual operating expenses 2022, up 17.83% from previous year.
  • Sotera Health Company reported a annual operating expenses of 261.93 Million USD in annual operating expenses 2021, up 10.27% from previous year.
  • Sotera Health Company reported a quarterly operating expenses of 77.51 Million USD for 2024 Q3, up 48.6% from previous quarter.
  • Sotera Health Company reported a quarterly operating expenses of 51.81 Million USD for 2024 Q1, up 30.37% from previous quarter.

Annual Operating Expenses Chart of Sotera Health Company (2023 - 2018)

Historical Annual Operating Expenses of Sotera Health Company (2023 - 2018)

Year Operating Expenses Operating Expenses Growth
2023 300.46 Million USD -49.17%
2022 308.65 Million USD 17.83%
2021 261.93 Million USD 10.27%
2020 237.55 Million USD 15.29%
2019 206.04 Million USD 7.68%
2018 191.33 Million USD 0.0%

Peer Operating Expenses Comparison of Sotera Health Company

Name Operating Expenses Operating Expenses Difference
Bionano Genomics, Inc. 148.99 Million USD -101.665%
Prenetics Global Limited 60.73 Million USD -394.703%
Star Equity Holdings, Inc. 16.27 Million USD -1746.522%
CareDx, Inc 277.76 Million USD -8.172%
Exact Sciences Corporation 2.06 Billion USD 85.418%
Exagen Inc. 52.29 Million USD -474.582%
Inotiv, Inc. 246.9 Million USD -21.694%
Guardant Health, Inc. 901.62 Million USD 66.675%
Biodesix, Inc. 77.41 Million USD -288.104%
BioNexus Gene Lab Corp. 3.92 Million USD -7558.92%
Precipio, Inc. 13.63 Million USD -2103.153%
iSpecimen Inc. 16.27 Million USD -1745.924%
Natera, Inc. 938.98 Million USD 68.001%
Aspira Women's Health Inc. 24.11 Million USD -1146.023%
Standard BioTools Inc. 113.48 Million USD -164.753%
23andMe Holding Co. 420.73 Million USD 28.585%
Castle Biosciences, Inc. 242.78 Million USD -23.759%
Personalis, Inc. 128.14 Million USD -134.475%
Aclaris Therapeutics, Inc. 110.52 Million USD -171.853%
Applied DNA Sciences, Inc. 16.48 Million USD -1722.473%
OpGen, Inc. 30.65 Million USD -880.059%
T2 Biosystems, Inc. 41.49 Million USD -624.119%
Myriad Genetics, Inc. 600.1 Million USD 49.931%
ICON Public Limited Company 755.64 Million USD 60.237%
NeoGenomics, Inc. 341.25 Million USD 11.952%
Star Equity Holdings, Inc. 16.27 Million USD -1746.522%
IDEXX Laboratories, Inc. 1.09 Billion USD 72.506%
RadNet, Inc. 268.87 Million USD -11.748%
MDxHealth SA 71.25 Million USD -321.671%
Psychemedics Corporation 11.33 Million USD -2551.015%
Illumina, Inc. 3.81 Billion USD 92.12%
Check-Cap Ltd. 19.28 Million USD -1457.868%
Twist Bioscience Corporation 354.18 Million USD 15.166%
DarioHealth Corp. 62.17 Million USD -383.274%
Fulgent Genetics, Inc. 171.9 Million USD -74.785%
Sera Prognostics, Inc. 39.91 Million USD -652.727%
ENDRA Life Sciences Inc. 10.52 Million USD -2755.941%
OPKO Health, Inc. 574.68 Million USD 47.716%
Medpace Holdings, Inc. 187.68 Million USD -60.095%
Neogen Corporation 405.23 Million USD 25.854%
Intelligent Bio Solutions Inc. 11.7 Million USD -2466.155%
Prenetics Global Limited 60.73 Million USD -394.703%
Mainz Biomed B.V. 27.15 Million USD -1006.512%
bioAffinity Technologies, Inc. 8.76 Million USD -3328.082%
Trinity Biotech plc 46.49 Million USD -546.233%
Neuronetics, Inc. 82.25 Million USD -265.268%
bioAffinity Technologies, Inc. 8.76 Million USD -3328.082%